Free Trial

Edap Tms (NASDAQ:EDAP) Earns Hold Rating from Analysts at StockNews.com

Edap Tms logo with Medical background

Investment analysts at StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a research note issued on Tuesday. The brokerage set a "hold" rating on the medical equipment provider's stock.

Other equities research analysts have also issued reports about the stock. Jefferies Financial Group restated a "hold" rating and issued a $2.00 price objective (down from $8.00) on shares of Edap Tms in a report on Friday, April 4th. HC Wainwright restated a "buy" rating and set a $19.00 target price on shares of Edap Tms in a research note on Friday, March 28th. Finally, Piper Sandler cut their price objective on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating on the stock in a report on Friday, March 28th.

Read Our Latest Analysis on EDAP

Edap Tms Trading Up 1.4 %

Shares of EDAP stock traded up $0.03 on Tuesday, hitting $2.15. The stock had a trading volume of 28,177 shares, compared to its average volume of 95,910. The company's 50 day moving average price is $2.01 and its 200-day moving average price is $2.30. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.40. The firm has a market capitalization of $79.77 million, a P/E ratio of -3.31 and a beta of 0.12. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The firm had revenue of $22.69 million during the quarter, compared to analysts' expectations of $20.83 million. Analysts anticipate that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Rock Springs Capital Management LP boosted its holdings in shares of Edap Tms by 1.5% in the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock valued at $3,518,000 after acquiring an additional 23,800 shares during the period. Schonfeld Strategic Advisors LLC boosted its stake in Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock worth $355,000 after purchasing an additional 52,500 shares during the period. Millennium Management LLC grew its position in Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after purchasing an additional 33,558 shares during the last quarter. BNP Paribas Financial Markets grew its position in Edap Tms by 111.5% during the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after purchasing an additional 25,650 shares during the last quarter. Finally, Jane Street Group LLC increased its stake in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after purchasing an additional 73,361 shares during the period. Institutional investors and hedge funds own 62.74% of the company's stock.

About Edap Tms

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

Featured Stories

Should You Invest $1,000 in Edap Tms Right Now?

Before you consider Edap Tms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.

While Edap Tms currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines